And thank you for joining us on today's conference call to discuss the financial results for Asana, Inc.'s fourth quarter and fiscal year 2026. With me on today's call are Dan Rogers, our Chief ...
When the US Food and Drug Administration (FDA) approved benzgalantamine (Zunveyl) in July 2024 for Alzheimer’s disease, it ...
Biohaven Ltd. (Biohaven or the Company), a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat a broad range ...
Herrera, A. (2026) Team‑Level Guide for Prompting, Governance, and Value Delivery. Open Journal of Business and Management, 14, 925-938. doi: 10.4236/ojbm.2026.142054 .
Fourth quarter 2025 revenue from continuing operations of $24.8 million, up 20% year-over-year; Full year 2025 revenue of $96.2 million, up 29% year-over-year GAAP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results